Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
Open Access
- 10 November 2010
- Vol. 117 (9), 1812-1818
- https://doi.org/10.1002/cncr.25595
Abstract
BACKGROUND: Hyperinsulinemia and the metabolic syndrome are both risk factors for breast cancer. It is not clear if diabetes is associated with the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. METHODS: The authors reviewed the medical histories of 6052 women with a BRCA1 or BRCA2 mutation, half of whom had been diagnosed with breast cancer. They estimated the odds ratio for breast cancer, given a self‐report of diabetes. They then estimated the hazard ratio for a new diagnosis of diabetes associated with a history of breast cancer. RESULTS: There was no excess of diabetes in the period before the diagnosis of breast cancer, compared with controls with no diagnosis of breast cancer. The risk of diabetes was doubled among BRCA carriers in the 15‐year period after the diagnosis of breast cancer (relative risk, 2.0; 95% confidence interval [CI], 1.4‐2.8; P = .0001), compared with carriers without cancer. The risk was particularly high for women with a body mass index (BMI) >25.0 kg/m2 (odds ratio, 5.8; 95% CI, 4.0‐8.6; P = .0001). CONCLUSIONS: After a diagnosis of breast cancer, women with a BRCA1 or BRCA2 mutation face a 2‐fold increase in the risk of diabetes, which is exacerbated by a high BMI. Cancer 2011. © 2010 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registryBreast Cancer Research and Treatment, 2010
- Beta-cell failure in the pathogenesis of type 2 diabetes mellitusCurrent Diabetes Reports, 2004
- Long‐term risk of malignant neoplasm associated with gestational glucose intoleranceCancer, 2003
- Central obesity and breast cancer risk: a systematic reviewObesity Reviews, 2003
- The Emergence of the Metabolic Syndrome with MenopauseJournal of Clinical Endocrinology & Metabolism, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 2003
- Pancreatic beta-cell loss and preservation in type 2 diabetesClinical Therapeutics, 2003
- Polycystic ovary syndrome and cancerHuman Reproduction Update, 2001
- Metabolic disorders and breast cancer risk (United States)Cancer Causes and Control, 2001